Pharmaceutical & Biopharmaceutical Contract Manufacturing Market to Grow with a CAGR of 6.10% through 2030

Surge in research and development activities is expected to drive the Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Pharmaceutical & Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market stood at USD 13.05 Billion in 2024 and is anticipated to grow with a CAGR of 6.10% through 2030. Initiatives taken by government based on pharmaceutical & biopharmaceutical contract manufacturing has led to favorable market conditions for the Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market. Several factors contribute to the growth of various pharmaceutical & biopharmaceutical contract manufacturing products.

Intensified R&D investments, particularly in areas such as monoclonal antibodies, gene and cell therapies, mRNA-based vaccines, and biosimilars, have expanded the need for advanced manufacturing capabilities. Many pharmaceutical and biotechnology firms, especially small and mid-sized enterprises, lack the infrastructure or in-house expertise to handle the intricate production processes required for these therapies. As a result, they are turning to specialized CDMOs to provide the necessary technological resources, regulatory compliance support, and scalable production platforms.

One of the key areas of government focus has been the enhancement of domestic manufacturing capacity. In regions such as North America, Europe, and Asia, governments are offering financial incentives, tax credits, and infrastructure support to encourage the establishment and expansion of contract manufacturing facilities. These efforts are aimed at reducing reliance on foreign production, mitigating supply chain disruptions, and reinforcing national preparedness for health emergencies. For instance, during the COVID-19 pandemic, many governments partnered with contract manufacturers to ensure timely production of vaccines and essential biologics.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market”

The Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market is segmented into product type, service, regional distribution, and company.

Based on Product Type, Finished Dosage Formulation have emerged as the dominating segment in the Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market in 2024. A key driver behind the segment’s dominance is the increasing need for pharmaceutical companies to reduce costs and accelerate time-to-market. Producing FDFs involves stringent quality control, regulatory compliance, and the use of advanced technologies for processes such as coating, granulation, aseptic filling, and packaging. To avoid the substantial investment required to build and maintain such capabilities in-house, many companies, particularly small and mid-sized enterprises, turn to experienced contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs).

Based on Region, Asia Pacific have emerged as the fastest growing region in the Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market in 2024. The region's large and diverse population provides access to a broad patient base for clinical trials, making it an attractive destination for global pharmaceutical companies looking to outsource both early- and late-stage drug manufacturing. In addition, ongoing investments in advanced manufacturing technologies, including biologics and sterile drug production, have significantly enhanced the technical capacity of contract manufacturing organizations (CMOs) in the region.

Major companies operating in Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market are:

• Jubilant Pharmova Limited
• JRS PHARMA GmbH & Co.
• Boehringer Ingelheim GmbH
• Lonza Group
• Rentschler Biotechnologie GmbH
• Inno Biologics Sdn Bhd
• INCOG BioPharma Services
• Baxter Biopharma Solutions
• Catalent Pharma Solutions
• Kemwell Biopharma Private Limited

Download Free Sample Report

Customers can also request for 10% free customization on this report

“One of the most prominent applications of nanotechnology in this market lies in the formulation of nanoparticle-based drug delivery systems, such as liposomes, solid lipid nanoparticles, polymeric nanoparticles, and dendrimers. These nanoscale delivery vehicles significantly enhance the bioavailability, stability, and controlled release of active pharmaceutical ingredients (APIs), especially those with poor solubility or short half-lives. As a result, CDMOs offering expertise in nanoformulation technologies are becoming highly sought after by pharmaceutical and biotech firms developing complex therapies”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Pharmaceutical & Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Active Pharmaceutical Ingredients (API), Finished Dosage Formulation, Advanced Drug Delivery Products, Over the Counter (OTC) Medicines, Others), By Service (Pharmaceutical Manufacturing Services, Biologics Manufacturing Services, Drug Development Services, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com